TORONTO, Sept. 27, 2018 /CNW/ - Evergreen Pacific Insurance Corporation ("Evergreen Pacific") announces it has signed a Letter of Intent with Anahit International Corp. ("Anahit") to form a joint venture partnership (the "Partnership") for select international markets exclusively on Evergreen Pacific's BuyWell.com ecosystem, which is comprised of educational, clinical and e-commerce marketplace elements focused on making health and wellness products and services affordable and accessible to patients. Evergreen Pacific will also rely upon Anahit to formulate and to manufacture private label cannabinoid-infused products for BuyWell.com to be marketed and sold in select international markets exclusively on the BuyWell.com ecosystem.
Commenting on the Partnership, Evergreen Pacific CEO Robert Wilson said, "With Anahit, BuyWell.com now will have the ability to offer a wide range of private label health and wellness products containing cannabinoids, for distribution globally through the BuyWell.com ecosystem."
He continued, "Together, Evergreen Pacific and Anahit will develop powerful business-to-business and business-to-consumer sales and distribution solutions for Mexico and select Latin American markets, leveraging our buying power and technology, and Anahit's local knowledge, product development and international manufacturing capabilities."
About Evergreen Pacific
Evergreen Pacific Insurance Corporation is a financial-services holding company. Evergreen Pacific owns, operates, and invests in businesses involved in designing, developing and distributing highly innovative insurance products and risk management solutions. www.evergreenpacific.ca
About Anahit International Corp.
Anahit International Corp. is dedicated to producing the highest quality cannabis products within emerging markets. Our vision is to become the most trusted high-end supply partner for cannabis and cannabis products to enable our corporate customers to harness the therapeutic properties of the plant in tomorrow's medicines
Anahit's strategy is to aggressively build well-integrated local operations within key regions with a focus on the local and export medical markets. Currently, the Company has operations in Canada and Jamaica and is rapidly expanding within the LATAM region.
The information contained in this news release is provided for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of Evergreen Pacific Insurance Company Ltd. (EPIC) or other related entities. The information contained herein is not investment or financial product advice and is not intended to be used as the basis for making an investment decision. The views, opinions and advice provided in this news release are provided for information purposes only. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this news release. Except for statements of historical fact, this news release may contain certain "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. This news release does not constitute an offer of shares for sale in the United States or to any person that is, or is acting for the account or benefit of, any U.S. person as defined in Regulation S under the United States Securities Act of 1933 (as amended the "Securities Act"), or in any other jurisdiction in which such an offer would be illegal. Evergreen's shares have not been and will not be registered under the Securities Act.
SOURCE Evergreen Pacific Insurance Corporation
For further information: Evergreen Pacific Insurance Corporation: Gordon Forstner, Vice President, Communications, 416-560-8056, [email protected]